Key result
Asciminib preserves vascular and endothelial function, supporting a favorable cardiovascular safety profile.
Authors
Loading...
Should not yet change TKI selection in CML; leaves open clinical CV benefit versus vascular-toxic agents.
Gover‐Proaktor et al. (2026) studied this question. Asciminib preserves vascular and endothelial function, supporting a favorable cardiovascular safety profile.